PLoS One:一个预测猪链球菌听力损失风险的评分系统

2020-02-15 AlexYang MedSci原创

猪链球菌(S.suis)病是一种新兴的人畜共患疾病,并且在南亚患病率较高。在全球范围内已经报道了超过1500个案例,主要分布在泰国,其次是越南。该疾病能够导致人类脑膜炎,最常见的患者并发症为感觉神经性听力损失(SNHL)。早期的诊断和治疗对预防严重的神经并发症是非常重要的。最近,有研究人员开发了一个易用的风险评分系统来促进可能发展为听力损失患者的S.suis的早期诊断。研究数据来源于13年的S.s

猪链球菌(S.suis)病是一种新兴的人畜共患疾病,并且在南亚患病率较高。在全球范围内已经报道了超过1500个案例,主要分布在泰国,其次是越南。该疾病能够导致人类脑膜炎,最常见的患者并发症为感觉神经性听力损失(SNHL)。早期的诊断和治疗对预防严重的神经并发症是非常重要的。

最近,有研究人员开发了一个易用的风险评分系统来促进可能发展为听力损失患者的S.suis的早期诊断。研究数据来源于13年的S.suis患者记录,并利用了单变量和多变量逻辑回归开发了一个预测模型。研究人员利用显著的预测因子系数构建了临床风险评分,还使用操作者特征曲线下面积(AuROC)来鉴定模型区分能力。研究共包括了133名患者,听力损失的发生率为31.6%(n=42)。S.suis听力损失的显著预测因子包括脑膜炎、生肉消费和眩晕。预测评分范围为0-4,修正后鉴定出81.95%的患者处于S.suis听力损失风险中。他们的模型表现出了良好的预测能力(AuROC: 0.859; 95%CI 0.785-0.933)和校准能力(AuROC: 0.860; 95%CI 0.716-0.953)。

最后,研究人员指出,他们的风险评分系统是首个为S.suis听力损失开发的系统。研究人员也指出了需要进一步的研究来优化评分系统并在推荐临床使用之前调查其外部有效性。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1790380, encodeId=9d431e9038050, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon Sep 14 11:27:00 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079205, encodeId=2aa220e920536, content=<a href='/topic/show?id=9078682059e' target=_blank style='color:#2F92EE;'>#猪链球菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68205, encryptionId=9078682059e, topicName=猪链球菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Thu Nov 19 08:27:00 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306479, encodeId=dcdc13064e9df, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Feb 17 04:27:00 CST 2020, time=2020-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555307, encodeId=6446155530ee0, content=<a href='/topic/show?id=f367681e434' target=_blank style='color:#2F92EE;'>#猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68174, encryptionId=f367681e434, topicName=猪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec214601917, createdName=muzishouyi, createdTime=Mon Feb 17 04:27:00 CST 2020, time=2020-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624077, encodeId=3b0a16240e736, content=<a href='/topic/show?id=69699666026' target=_blank style='color:#2F92EE;'>#链球菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96660, encryptionId=69699666026, topicName=链球菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787f20641298, createdName=liuquanmn, createdTime=Mon Feb 17 04:27:00 CST 2020, time=2020-02-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1790380, encodeId=9d431e9038050, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon Sep 14 11:27:00 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079205, encodeId=2aa220e920536, content=<a href='/topic/show?id=9078682059e' target=_blank style='color:#2F92EE;'>#猪链球菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68205, encryptionId=9078682059e, topicName=猪链球菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Thu Nov 19 08:27:00 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306479, encodeId=dcdc13064e9df, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Feb 17 04:27:00 CST 2020, time=2020-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555307, encodeId=6446155530ee0, content=<a href='/topic/show?id=f367681e434' target=_blank style='color:#2F92EE;'>#猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68174, encryptionId=f367681e434, topicName=猪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec214601917, createdName=muzishouyi, createdTime=Mon Feb 17 04:27:00 CST 2020, time=2020-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624077, encodeId=3b0a16240e736, content=<a href='/topic/show?id=69699666026' target=_blank style='color:#2F92EE;'>#链球菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96660, encryptionId=69699666026, topicName=链球菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787f20641298, createdName=liuquanmn, createdTime=Mon Feb 17 04:27:00 CST 2020, time=2020-02-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1790380, encodeId=9d431e9038050, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon Sep 14 11:27:00 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079205, encodeId=2aa220e920536, content=<a href='/topic/show?id=9078682059e' target=_blank style='color:#2F92EE;'>#猪链球菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68205, encryptionId=9078682059e, topicName=猪链球菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Thu Nov 19 08:27:00 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306479, encodeId=dcdc13064e9df, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Feb 17 04:27:00 CST 2020, time=2020-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555307, encodeId=6446155530ee0, content=<a href='/topic/show?id=f367681e434' target=_blank style='color:#2F92EE;'>#猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68174, encryptionId=f367681e434, topicName=猪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec214601917, createdName=muzishouyi, createdTime=Mon Feb 17 04:27:00 CST 2020, time=2020-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624077, encodeId=3b0a16240e736, content=<a href='/topic/show?id=69699666026' target=_blank style='color:#2F92EE;'>#链球菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96660, encryptionId=69699666026, topicName=链球菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787f20641298, createdName=liuquanmn, createdTime=Mon Feb 17 04:27:00 CST 2020, time=2020-02-17, status=1, ipAttribution=)]
    2020-02-17 ysjykql
  4. [GetPortalCommentsPageByObjectIdResponse(id=1790380, encodeId=9d431e9038050, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon Sep 14 11:27:00 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079205, encodeId=2aa220e920536, content=<a href='/topic/show?id=9078682059e' target=_blank style='color:#2F92EE;'>#猪链球菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68205, encryptionId=9078682059e, topicName=猪链球菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Thu Nov 19 08:27:00 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306479, encodeId=dcdc13064e9df, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Feb 17 04:27:00 CST 2020, time=2020-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555307, encodeId=6446155530ee0, content=<a href='/topic/show?id=f367681e434' target=_blank style='color:#2F92EE;'>#猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68174, encryptionId=f367681e434, topicName=猪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec214601917, createdName=muzishouyi, createdTime=Mon Feb 17 04:27:00 CST 2020, time=2020-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624077, encodeId=3b0a16240e736, content=<a href='/topic/show?id=69699666026' target=_blank style='color:#2F92EE;'>#链球菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96660, encryptionId=69699666026, topicName=链球菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787f20641298, createdName=liuquanmn, createdTime=Mon Feb 17 04:27:00 CST 2020, time=2020-02-17, status=1, ipAttribution=)]
    2020-02-17 muzishouyi
  5. [GetPortalCommentsPageByObjectIdResponse(id=1790380, encodeId=9d431e9038050, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon Sep 14 11:27:00 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079205, encodeId=2aa220e920536, content=<a href='/topic/show?id=9078682059e' target=_blank style='color:#2F92EE;'>#猪链球菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68205, encryptionId=9078682059e, topicName=猪链球菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Thu Nov 19 08:27:00 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306479, encodeId=dcdc13064e9df, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Feb 17 04:27:00 CST 2020, time=2020-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555307, encodeId=6446155530ee0, content=<a href='/topic/show?id=f367681e434' target=_blank style='color:#2F92EE;'>#猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68174, encryptionId=f367681e434, topicName=猪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec214601917, createdName=muzishouyi, createdTime=Mon Feb 17 04:27:00 CST 2020, time=2020-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624077, encodeId=3b0a16240e736, content=<a href='/topic/show?id=69699666026' target=_blank style='color:#2F92EE;'>#链球菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96660, encryptionId=69699666026, topicName=链球菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787f20641298, createdName=liuquanmn, createdTime=Mon Feb 17 04:27:00 CST 2020, time=2020-02-17, status=1, ipAttribution=)]

相关资讯

Environ Health:噪声峰度、NOX3遗传变异和生活方式与噪音诱导的听力损失相关性分析

噪音诱导的听力损失(NIHL)是一种复杂的疾病,由环境和遗传风险因素引起。最近,有研究人员探索了噪声峰度、NOX3遗传变异和生活方式与NIHL的相关性情况。研究是一个案例对照研究,包括了307名NIHL患者和307名匹配的对照。研究发现,那些暴露在复杂的噪音中的参与者比那些暴露在稳定的噪音中的参与者具有更高的NIHL风险(调整后OR=1.806, P=0.002)。在NOX3 rs12195525

Otolaryngol Head Neck Surg:糖尿病对突发感觉神经性听力损失影响研究

最近,有研究人员调查了糖尿病对先天突发感觉神经性听力损失(ISSNHL)治疗的影响情况。研究是一个回顾性的研究,在一个三级转诊中心进行。研究共包括了403名ISSNHL患者,并在2015年1月到2018年12月之间进行了住院治疗。所有患者均接受统一的高剂量类固醇治疗和挽救性类固醇注射治疗方案,并在治疗开始后3个月进行结果评估。研究人员比较了患有和不患有糖尿病ISSNHL患者的临床参数和治疗结果情况

盘点:听力损失治疗研究

【1】Am J Otolaryngol:听觉剥夺成年人中的耳蜗移植分析 在耳鼻喉科领域,听觉剥夺经常被认为是一种耳蜗移植(CI)后良好听力结果的一个负面预后因素,尽管越来越多的文献表明上述情况未必完全属实。最近,有研究人员评估了CI在听力剥夺患者中的结果情况,并与非剥夺患者的结果进行了比较,之后还评估了剥夺时间怎样对CI结果产生影响,以及双边剥夺怎样能够影响结果,并与单边剥夺进行

Hum Mutat:POLD1变异导致聚合酶活性减少从而引起无症状特征听力损失

DNA聚合酶δ的催化亚单元是由POLD1编码,负责合成DNA的滞后链。据报道,聚合酶活性和外切酶活性结构域的单个不同的POLD1变异能够引起综合症性耳聋,并且只是多系统代谢紊乱或易患癌症的一部分。然而,POLD1不同基因型组合的表型在人类中尚未阐释。最近,有研究人员在一个多重家族分离常染色体隐性遗传非综合征性感音神经性耳聋(NS-SNHL)家族中,发现了其中5名成员具有新的复合杂合子POLD1变异

PLoS One:耳蜗功能异常与苯乙烯接触有关

职业性接触苯乙烯与发生听力损失可能性的增加相关。然而,人类听觉系统中发生病变的位点仍旧不知道。最近,有研究人员调查了苯乙烯接触对人类耳蜗可能的负面影响。研究包括了98名来自于玻璃纤维增强塑料工业的98名职业接触苯乙烯的男性工人(55mg/m3),并利用纯音听力测定(1000-16000Hz)、畸变产物耳声发射(DPOAEs)he 听觉脑干响应(ABR)评估了听力功能情况。研究人员将结果与111名接

Int J Audiol:全球和局部地区助听器使用情况分析

最近,有研究人员评估了关于助听器的全球和局部地区的需求情况,未满足的需求情况以及获得助听器的情况,包括了助听器的使用对发病率效的影响情况。他们的研究基于全球疾病数据库。研究样本包括了那些听力损伤且需要助听器的个体,并根据严重度分为中度、中重度和重度。研究发现,全球共有4.014亿人需要助听器。然而,他们中的大多数(83%)都不使用助听器,且在一些非洲区域该比例更高(90%)。助听器的覆盖能够减少1